Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

TACI Is Required for Efficient Plasma Cell Differentiation in Response to T-Independent Type 2 Antigens
Mantchev, George T., Cortesão, Catarina S., Rebrovich, Michelle, Bram, Richard J. , Cascalho, Marília

The Journal of Immunology | April 18, 2014 | Volume: 179 | Issue: 4 | Pages: 2282-2288

10.4049/jimmunol.179.4.2282 | PMID 17675489 Get It

Abstract The control of systemic infection by encapsulated microorganisms requires T-independent type II (TI-2) Ab responses to bacterial polysaccharides. To understand how such responses evolve, we explored the function of transmembrane activator calcium modulator and cyclophilin ligand interactor (TACI), a member of the TNFR family, required for TI-2 Ab production. Quasimonoclonal (QM) mice produce robust TI-2 responses to 4-hydroxy-3-nitrophenylacetate (NP)-Ficoll, owing to the high precursor frequency of NP-specific B cells in the marginal zone of the spleen. QM mice that lack TACI produce decreased numbers of IgM (2-fold) and IgG (1.6-fold) NP-specific ASCs, compared with TACI-positive QM mice in response to immunization with NP-Ficoll. Our studies indicate that TACI acts at a remote time from activation because TACI is not necessary for activation and proliferation of B cells both in vitro and in vivo. Instead, TACI-deficient QM B cells remained in the cell cycle longer than TACI-proficient QM cells and had impaired plasma cell differentiation in response to NP-Ficoll. We conclude that TACI has dual B cell-autonomous functions, inhibiting prolonged B cell proliferation and stimulating plasma cell differentiation, thus resolving the longstanding paradox that TACI may have both B cell-inhibitory and -stimulatory functions. By promoting plasma cell differentiation earlier during clonal expansion, TACI may decrease the chances of autoantibody production by somatic hypermutation of Ig genes in response to T-independent Ags.
Induction of CD56 and TCR-Independent Activation of T Cells with Aging
Lemster, Bonnie , Michel, Joshua J. , Montag, David T. , Paat, John J., Studenski, Stephanie A. , Vallejo, Abbe N. , Newman, Anne B.

The Journal of Immunology | April 18, 2014 | Volume: 180 | Issue: 3 | Pages: 1979-1990

10.4049/jimmunol.180.3.1979 | PMID 18209097 Get It

Abstract Degeneration of the thymus and severe contraction of the T cell repertoire with aging suggest that immune homeostasis in old age could be mediated by distinct effectors. Therefore, receptors expressed on T cells as they undergo senescence in vitro, as well as those displayed by circulating T cells during normal chronologic aging, were examined. Monitoring of T cells driven to senescence showed de novo induction of CD56, the prototypic receptor of NK cells. Analysis of fresh T cells in peripheral blood showed an age-dependent induction of CD56. These unusual T cells expressed high levels of Bcl2, p16, and p53, and had limited, or completely lost, ability to undergo cell division, properties consistent with senescence. CD56 cross-linking without TCR ligation on CD56+ T cells resulted in extensive protein phosphorylation, NF-κB activation, and Bax down-regulation. CD56 cross-linking was also sufficient to drive production of various humoral factors. These data suggest that the immunologic environment in old age is functionally distinct, rather than being a dysfunctional version of that seen at a young age. CD56+ T cells are unique effectors capable of mediating TCR-independent immune cascades that could be harnessed to enhance protective immunity in the elderly.
H2E -Derived Eα52-68 Peptide Presented by H2Ab Interferes with Clonal Deletion of Autoreactive T Cells in Autoimmune Thyroiditis
Brown, Nicholas K. , David, Chella S., Kong, Yi-chi M., McCormick, Daniel

The Journal of Immunology | April 18, 2014 | Volume: 180 | Issue: 10 | Pages: 7039-7046

10.4049/jimmunol.180.10.7039 | PMID 18453626 Get It

Abstract Susceptibility and resistance to experimental autoimmune thyroiditis is encoded by MHC H2A genes. We reported that traditionally resistant B10 (H2b) mice permit thyroiditis induction with mouse thyroglobulin (mTg) after depleting regulatory T cells (Tregs), supporting Ab presentation to thyroiditogenic T cells. Yet, Eak transgenic mice, expressing Ab and normally absent Eb molecules (E+B10 mice), are susceptible to thyroiditis induction without Treg depletion. To explore the effect of Eb expression on mTg presentation by Ab, seven putative Ab-binding, 15–16-mer peptides were synthesized. Five were immunogenic for both B10 and E+B10 mice. The effect of Eb expression was tested by competition with an Eα52-68 peptide, because Eα52-68 occupies ∼15% of Ab molecules in E+B10 mice, binding with high affinity. Eα52-68 competitively reduced the proliferative response to mTg, mTg1677, and mTg2342 of lymph node cells primed to each Ag. Moreover, mTg1677 induced mild thyroiditis in Treg-depleted B10 mice, and in E+B10 mice without the need for Treg depletion. Eα52-68 competition with mTg-derived peptides may impede clonal deletion of pathogenic, mTg-specific T cells in the thymus.
Combined Flexor Carpi Radialis Tear and Flexor Carpi Radialis Brevis Tendinopathy Identified by Ultrasound: A Case Report
Smith, Jay , Kakar, Sanjeev

PM&R | April 18, 2014 | Volume: 6 | Issue: 10 | Pages: 956-959

10.1016/j.pmrj.2014.04.005 | PMID 24751680 Get It

A 63‐year‐old right‐handed office worker presented with acute right wrist pain after lifting a heavy file at work. Results of a clinical examination suggested flexor carpi radialis tendinopathy. Diagnostic ultrasound (US) not only detected a complete flexor carpi radialis tear but also revealed the presence of a concomitant flexor carpi radialis brevis (FCRB) tendon with associated tenosynovitis. The ability of US to correctly identify the FCRB has not been previously reported. Furthermore, the US appearance of FCRB tendinopathy and tenosynovitis has not been described. High‐resolution US can identify the FCRB muscle‐tendon in the wrist region. Sonologists and sonographers should be aware of the US appearance of the FCRB as well as the potential for the FCRB to contribute to radial wrist pain syndromes.
Novel Approach to Inhibit Asthma-Mediated Lung Inflammation Using Anti-CD147 Intervention
Gwinn, William M., Damsker, Jesse M. , Falahati, Rustom, Okwumabua, Ifeanyi, Kelly-Welch, Ann E., Keegan, Achsah , Vanpouille, Christophe , Dent, Lindsay A. , Constant, Stephanie L., Lee, James J. , Leitenberg, David , Bukrinsky, Michael

The Journal of Immunology | April 18, 2014 | Volume: 177 | Issue: 7 | Pages: 4870-4879

10.4049/jimmunol.177.7.4870 | PMID 16982929 Get It

Abstract Extracellular cyclophilins have been well described as chemotactic factors for various leukocyte subsets. This chemotactic capacity is dependent upon interaction of cyclophilins with the cell surface signaling receptor CD147. Elevated levels of extracellular cyclophilins have been documented in several inflammatory diseases. We propose that extracellular cyclophilins, via interaction with CD147, may contribute to the recruitment of leukocytes from the periphery into tissues during inflammatory responses. In this study, we examined whether extracellular cyclophilin-CD147 interactions might influence leukocyte recruitment in the inflammatory disease allergic asthma. Using a mouse model of asthmatic inflammation, we show that 1) extracellular cyclophilins are elevated in the airways of asthmatic mice; 2) mouse eosinophils and CD4+ T cells express CD147, which is up-regulated on CD4+ T cells upon activation; 3) cyclophilins induce CD147-dependent chemotaxis of activated CD4+ T cells in vitro; 4) in vivo treatment with anti-CD147 mAb significantly reduces (by up to 50%) the accumulation of eosinophils and effector/memory CD4+ T lymphocytes, as well as Ag-specific Th2 cytokine secretion, in lung tissues; and 5) anti-CD147 treatment significantly reduces airway epithelial mucin production and bronchial hyperreactivity to methacholine challenge. These findings provide a novel mechanism whereby asthmatic lung inflammation may be reduced by targeting cyclophilin-CD147 interactions.
Complement-Dependent Control of Teratoma Formation by Embryonic Stem Cells
Koch, Cody A., Jordan, Corinne E., Platt, Jeffrey L.

The Journal of Immunology | April 18, 2014 | Volume: 177 | Issue: 7 | Pages: 4803-4809

10.4049/jimmunol.177.7.4803 | PMID 16982921 Get It

Abstract The fetus has pluripotent stem cells that when transferred to mature individuals can generate tumors. However, for reasons yet unknown, tumors form rarely in the fetus and/or the mother during normal gestation. We questioned whether the complement system might protect against tumor formation by pluripotent stem cells. Murine embryonic stem cells were notably more susceptible than cardiomyocytes differentiated from those cells to lysis by complement in heterologous and homologous sera. Treatment of embryonic stem cells with heterologous serum averted tumor formation after residual cells were transplanted into mice. Confirming the importance of homologous complement in preventing formation of tumors, untreated embryonic stem cells formed tumors more quickly in C3-deficient than in wild-type mice. Susceptibility of embryonic stem cells to complement required an intact alternative pathway and was owed at least in part to a relative deficiency of sialic acid on cell surfaces compared with differentiated cells. Susceptibility to complement and resistance to tumors was inversely related to the number of cells transferred. These findings show that formation of tumors from embryonic stem cells is controlled in part by the alternative pathway of complement and suggest that susceptibility to complement might represent a general property of pluripotent stem cells that can be exploited to prevent tumor formation.
Cutting Edge: Stimulation of Dopamine D4 Receptors Induce T Cell Quiescence by Up-Regulating Krüppel-Like Factor-2 Expression through Inhibition of ERK1/ERK2 Phosphorylation
Sarkar, Chandrani , Das, Shamik, Chakroborty, Debanjan , Chowdhury, Uttio Roy, Basu, Biswarup , Dasgupta, Partha, Basu, Sujit

The Journal of Immunology | April 18, 2014 | Volume: 177 | Issue: 11 | Pages: 7525-7529

10.4049/jimmunol.177.11.7525 | PMID 17114421 Get It

Abstract The neurotransmitter dopamine (DA) is an important regulator of human T cell functions. Although it has been observed that DA, by acting through the D1/D5, D2, and D3 receptors, can activate resting T cells by stimulating the release of cytokines and the expression of surface integrins and also inhibit the proliferation of activated T cells by down-regulating nonreceptor tyrosine kinases, there is not yet a report indicating the functional significance of the D4 DA receptors present in these cells. The present work, for the first time, demonstrates that the stimulation of D4 DA receptors in human T cells induces T cell quiescence by up-regulating lung Krüppel-like factor-2 expression through the inhibition of ERK1/ERK2 phosphorylation. These results reveal a new link between the nervous system and T cell quiescence and indicate that D4 DA receptor agonists may have a therapeutic value in diseases with uncontrolled T cell proliferation.
HLA Transgenic Mice Provide Evidence for a Direct and Dominant Role of HLA Class II Variation in Modulating the Severity of Streptococcal Sepsis
Nooh, Mohammed M. , El-Gengehi, Nagala, Kansal, Rita G. , David, Chella S., Kotb, Malak

The Journal of Immunology | April 18, 2014 | Volume: 178 | Issue: 5 | Pages: 3076-3083

10.4049/jimmunol.178.5.3076 | PMID 17312154 Get It

Abstract Our epidemiologic studies on invasive Group A Streptococci (GAS) infections identified specific HLA class II haplotypes/alleles conferring high-risk or protection from streptococcal toxic shock syndrome with a strong protection conferred by the DRB1*15/DQB1*06 haplotype. We used HLA-transgenic mice to provide an in vitro and in vivo validation for the direct role of HLA class II allelic variation in streptococcal toxic shock syndrome. When splenocytes from mice expressing the protective HLA-DQB1*06 (DQ6) allele were stimulated with a mixture of streptococcal superantigens (SAgs), secreted by the prevalent M1T1 strain, both proliferative and cytokine responses were significantly lower than those of splenocytes from mice expressing the neutral DRB1*0402/DQB1*0302 (DR4/DQ8) alleles (p < 0.001). In crisscross experiments, the presentation of SAgs to pure T cells from either the DQ6 or the DR4/DQ8 mice resulted in significantly different levels of response depending on the HLA type expressed on the APCs. Presentation by HLA-DQ6 APCs elicited significantly lower responses than the presentation by HLA-DR4/DQ8 APCs. Our in vitro data were supported by in vivo findings, as the DQ6 mice showed significantly longer survival post-i.v. infection with live M1T1 GAS (p < 0.001) and lower inflammatory cytokine responses as compared with the DR4/DQ8 mice (p < 0.01). The data presented here provide evidence for a direct role of HLA class II molecules in modulating responses to GAS SAgs and underscore the dominant role of HLA class II allelic variation in potentiating the severity of GAS systemic infections.
Fitness of Cell-Mediated Immunity Independent of Repertoire Diversity
AbuAttieh, Mouhammed, Rebrovich, Michelle, Wettstein, Peter J., Vuk-Pavlović, Zvezdana, Platt, Jeffrey L. , Limper, Andrew H. , Cascalho, Marília

The Journal of Immunology | April 18, 2014 | Volume: 178 | Issue: 5 | Pages: 2950-2960

10.4049/jimmunol.178.5.2950 | PMID 17312140 Get It

Abstract Fitness of cell-mediated immunity is thought to depend on TCR diversity; however, this concept has not been tested formally. We tested the concept using JH−/− mice that lack B cells and have TCR Vβ diversity <1% that of wild-type mice and quasimonoclonal (QM) mice with oligoclonal B cells and TCR Vβ diversity 7% that of wild-type mice. Despite having a TCR repertoire contracted >99% and defective lymphoid organogenesis, JH−/− mice rejected H-Y-incompatible skin grafts as rapidly as wild-type mice. JH−/− mice exhibited T cell priming by peptide and delayed-type hypersensitivity, although these responses were less than normal owing either to TCR repertoire contraction or defective lymphoid organogenesis. QM mice with TCR diversity contracted >90%, and normal lymphoid organs rejected H-Y incompatible skin grafts as rapidly as wild type mice and exhibited normal T cell priming and normal delayed-type hypersensitivity reactions. QM mice also resisted Pneumocystis murina like wild-type mice. Thus, cell-mediated immunity can function normally despite contractions of TCR diversity >90% and possibly >99%.
Conversion From Sildenafil to Tadalafil
Frantz, Robert P. , Durst, Louise A., Franco, Verónica , McDevitt, Susanne , Walker, Susan , Durst, Louise, Burger, Charles D. , Oudiz, Ronald J. , Bourge, Robert C. , Waxman, Aaron B. , Frantz, Robert P

Journal of Cardiovascular Pharmacology and Therapeutics | April 18, 2014 | Volume: 19 | Issue: 6 | Pages: 550-557

10.1177/1074248414528066 | PMID 24742768 Get It

Purpose: Among phosphodiesterase type 5 inhibitors, tadalafil offers clinicians a once-daily alternative to 3 times daily sildenafil for the treatment of pulmonary arterial hypertension (PAH). This study assessed the safety and patient satisfaction with conversion from sildenafil to tadalafil. Methods: In this multicenter, prospective, 6-month study, patients with PAH were instructed to take their last dose of sildenafil in the evening and initiate tadalafil 40 mg/d the next morning. Patients completed the Treatment Satisfaction Questionnaire for Medication at baseline and 30, 90, and 180 days after transition to assess PAH symptoms and patient satisfaction. Safety was assessed on the basis of recorded adverse events (AEs). Results: Of the 35 patients who met the study criteria, 56% were receiving ≥2 PAH therapies. At the time of transition, the sildenafil dose ranged from 40 to 300 mg/d, with 20% of the patients on >20 mg of sildenafil 3 times daily. Transition to tadalafil was generally well tolerated, and the incidence of common AEs, except for myalgia, appeared to decrease over time on tadalafil therapy. Five (14%) patients switched back to sildenafil. A greater percentage of patients were satisfied than were dissatisfied after conversion to tadalafil (55% vs 19% at 90 days), while 26% felt about the same degree of satisfaction. Conversion to tadalafil resulted in significant improvement in patient ratings of therapy convenience. Conclusions: Transition of patients from sildenafil to tadalafil was usually well tolerated, with improved convenience and may enhance treatment satisfaction.